Dr. David Aaron Eichenbaum , MD
Ophthalmology • St Petersburg, FL
4344 Central Ave
St Petersburg, FL 337111141
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. David Eichenbaum is listed in NPPES under Ophthalmology.
-
NPI assigned on July 5, 2006; this date does not establish years in practice.
-
Published CMS data list 93,487 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J2777 — Injection, faricimab-svoa, 0.1 mg: 47,820 service units.
- J2403 — Chloroprocaine hcl ophthalmic, 3% gel, 1 mg: 31,200 service units.
- J2781 — Injection, pegcetacoplan, intravitreal, 1 mg: 3,345 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
See all 27 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 347 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Prednisolone Acetate — 124 prescription fills, including refills.
- Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) — 45 prescription fills, including refills.
- Brimonidine Tartrate — 32 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 11 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in St Petersburg, FL (2024, 16 clinicians with data). Median for this group: 2,699. Middle half: 1,042 to 11,589.
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Florida (2024, 1,014 clinicians with data). Median for this group: 2,174. Middle half: 801 to 4,691.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 16,486 in 2020 to 93,487 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
4344 Central Ave
St Petersburg, FL 337111141
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 2 distinct additional practice-address records in Clearwater, FL; Tampa, FL. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: Pautler Cohen Findlay Eichenbaum White And Crane Mds Pa. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of South Florida College Of Medicine
2001
What Public CMS Data Show
Ophthalmology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
902 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $4,315,949 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $3,411,461 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
716 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$21,766 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $244,966.76 across 245 records.
By nature of payment (3 largest of 6)
- Consulting Fee: $138,402.25 across 76 records.
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $68,868.25 across 11 records.
- Compensation for serving as faculty or as a speaker for a medical education program: $21,724.00 across 6 records.
Reporting-company totals (3 largest of 18)
- Regeneron Pharmaceuticals, Inc.: $111,178.04 across 80 records.
- Apellis Pharmaceuticals, Inc.: $44,780.73 across 26 records.
- Ocular Therapeutix, Inc.: $31,608.81 across 34 records.
Research and ownership records are not included in these totals; they are in the table below.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
25 years (graduated 2001)
CMS Doctors and Clinicians data list 2001 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Eichenbaum has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Eichenbaum as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in St Petersburg and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in St Petersburg, FL (2024, 16 clinicians with data). Median for this group: 2,699. Middle half: 1,042 to 11,589.
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Florida (2024, 1,014 clinicians with data). Median for this group: 2,174. Middle half: 801 to 4,691.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Ophthalmology in St Petersburg, FL (2024, 16 clinicians with data). Median for this group: $283,561. Middle half: $147,798 to $794,630.
A higher Medicare-allowed amount than 95% of clinicians listed under Ophthalmology in Florida (2024, 1,014 clinicians with data). Median for this group: $239,067. Middle half: $86,567 to $537,508.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Ophthalmology in St Petersburg, FL (2024, 16 clinicians with data). Median for this group: $215,830. Middle half: $105,271 to $576,520.
A higher Medicare payment amount than 95% of clinicians listed under Ophthalmology in Florida (2024, 1,014 clinicians with data). Median for this group: $175,260. Middle half: $61,464 to $390,296.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Ophthalmology in St Petersburg, FL (2024, 18 clinicians with data). Median for this group: 372. Middle half: 163 to 913.
Fewer Part D prescriptions than 75% of clinicians listed under Ophthalmology in Florida (2024, 1,099 clinicians with data). Median for this group: 1,203. Middle half: 442 to 2,490.
Part D drug cost
Close to the middle for clinicians listed under Ophthalmology in St Petersburg, FL (2024, 18 clinicians with data). Median for this group: $18,710. Middle half: $8,067 to $89,584.
A lower Part D drug cost than 75% of clinicians listed under Ophthalmology in Florida (2024, 1,099 clinicians with data). Median for this group: $114,958. Middle half: $23,858 to $310,282.
30 active clinicians are listed under Ophthalmology with a practice address in St Petersburg, FL (1,582 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in St Petersburg
0% of these 30 clinicians have the CMS telehealth indicator.
50% of these 30 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 467% from 16,486 in 2020 to 93,487 in 2024.
- 2020: 16,486
- 2021: 14,031
- 2022: 20,083
- 2023: 47,756
- 2024: 93,487
-
Medicare-allowed amount
Medicare-allowed amount decreased 12% from $4,915,598 in 2020 to $4,315,949 in 2024.
- 2020: $4,915,598
- 2021: $4,343,255
- 2022: $4,034,600
- 2023: $4,068,213
- 2024: $4,315,949
-
Paid by Medicare
Paid by Medicare decreased 12% from $3,886,540 in 2020 to $3,411,461 in 2024.
- 2020: $3,886,540
- 2021: $3,453,142
- 2022: $3,173,997
- 2023: $3,202,712
- 2024: $3,411,461
-
Medicare Part D prescriptions
Medicare Part D prescriptions varied from year to year: 338 in 2020 and 347 in 2024.
- 2020: 338
- 2021: 284
- 2022: 370
- 2023: 350
- 2024: 347
-
30-day fills
30-day fills increased 54% from 465 in 2020 to 716 in 2024.
- 2020: 465
- 2021: 410
- 2022: 616
- 2023: 675
- 2024: 716
-
Part D drug cost
Part D drug cost increased 13% from $19,181 in 2020 to $21,766 in 2024.
- 2020: $19,181
- 2021: $13,023
- 2022: $21,044
- 2023: $25,067
- 2024: $21,766
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 18% from $211,236.39 in 2021 to $249,452.64 in 2025.
- 2021: $211,236.39
- 2022: $272,409.36
- 2023: $232,191.17
- 2024: $461,422.05
- 2025: $249,452.64
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 249 records totaling $249,452.64.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. |
Consulting Fee
Cash or cash equivalent
|
EYLEA HD | General | $13,260.00 |
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EYLEA HD | General | $11,050.00 |
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EYLEA HD | General | $11,050.00 |
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EYLEA HD | General | $11,050.00 |
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EYLEA HD | General | $11,050.00 |
| ABBVIE INC. |
Consulting Fee
Cash or cash equivalent
|
— | General | $10,762.50 |
| Apellis Pharmaceuticals, Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
Syfovre | General | $7,095.00 |
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EYLEA HD | General | $6,630.00 |
| Regeneron Pharmaceuticals, Inc. |
Consulting Fee
Cash or cash equivalent
|
EYLEA HD | General | $6,630.00 |
| Genentech, Inc. |
Consulting Fee
Cash or cash equivalent
|
Vabysmo | General | $6,300.00 |
| Apellis Pharmaceuticals, Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
Syfovre | General | $6,149.00 |
| Astellas Pharma US Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Izervay | General | $6,000.00 |
| Regeneron Pharmaceuticals, Inc. |
Consulting Fee
Cash or cash equivalent
|
EYLEA HD | General | $5,525.00 |
| Ocular Therapeutix, Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $5,000.00 |
| Apellis Pharmaceuticals, Inc. |
Consulting Fee
Cash or cash equivalent
|
Syfovre | General | $4,730.00 |
| Apellis Pharmaceuticals, Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
Syfovre | General | $4,730.00 |
| ABBVIE INC. |
Consulting Fee
Cash or cash equivalent
|
— | General | $4,100.00 |
| Ocular Therapeutix, Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $4,000.00 |
| Astellas Pharma US Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Izervay | General | $3,600.00 |
| Regeneron Pharmaceuticals, Inc. |
Consulting Fee
Cash or cash equivalent
|
EYLEA HD | General | $3,315.00 |
| Regeneron Pharmaceuticals, Inc. |
Consulting Fee
Cash or cash equivalent
|
EYLEA | General | $3,315.00 |
| Astellas Pharma US Inc |
Consulting Fee
Cash or cash equivalent
|
Izervay | General | $3,250.00 |
| Genentech, Inc. |
Consulting Fee
Cash or cash equivalent
|
Susvimo | General | $2,925.00 |
| Apellis Pharmaceuticals, Inc. |
Consulting Fee
Cash or cash equivalent
|
Syfovre | General | $2,838.00 |
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EYLEA HD | General | $2,763.00 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J2777
Injection, faricimab-svoa, 0.1 mg
|
47,820 | 171 | $100.00 | $34.28 |
|
J2403
Chloroprocaine hcl ophthalmic, 3% gel, 1 mg
|
31,200 | 21 | $2.00 | $0.64 |
|
J2781
Injection, pegcetacoplan, intravitreal, 1 mg
|
3,345 | 34 | $400.00 | $146.42 |
|
92134
Imaging of retina
|
1,966 | 810 | $64.94 | $40.37 |
|
J0177
Injection, aflibercept hd, 1 mg
|
1,720 | 55 | $750.00 | $328.39 |
|
J2782
Injection, avacincaptad pegol, 0.1 mg
|
1,720 | 15 | $300.00 | $108.59 |
|
67028
Injection of drug into eye
|
1,524 | 398 | $664.37 | $132.62 |
|
92014
Established patient complete exam of visual system
|
779 | 601 | $200.06 | $125.95 |
|
J0178
Injection, aflibercept, 1 mg
|
682 | 110 | $2000.00 | $831.90 |
|
Q5128
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg
|
470 | 27 | $1085.11 | $228.61 |
|
92250
Photography of the retina
|
412 | 379 | $144.17 | $37.14 |
|
92012
Established patient problem focused exam of visual system
|
395 | 275 | $150.07 | $89.36 |
|
92202
Extended exam of the back part of the eye with optic nerve drawing
|
338 | 249 | $40.00 | $15.76 |
|
J7312
Injection, dexamethasone, intravitreal implant, 0.1 mg
|
280 | 17 | $430.00 | $202.30 |
|
J2778
Injection, ranibizumab, 0.1 mg
|
225 | 29 | $1000.00 | $174.73 |
|
92004
New patient complete exam of visual system
|
177 | 177 | $268.90 | $148.79 |
|
92201
Extended exam of the back part of the eye with retinal drawing
|
90 | 78 | $50.00 | $25.33 |
|
J7999
Compounded drug, not otherwise classified
|
83 | 23 | $500.00 | $83.66 |
|
J3301
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
|
52 | 11 | $7.00 | $0.93 |
|
J3590
Unclassified biologics
|
41 | 22 | $6000.00 | $2661.70 |
|
76512
2d ultrasound scan of eye tissue and structures
|
34 | 18 | $154.41 | $49.77 |
|
92020
Exam of the internal drainage system of eye
|
34 | 22 | $52.94 | $27.49 |
|
92235
Exam of retinal blood vessels using a special camera after injection of a dye
|
33 | 33 | $200.00 | $161.23 |
|
J3490
Unclassified drugs
|
25 | 12 | $5520.00 | $2011.69 |
|
65800
Removal of eye fluid
|
15 | 11 | $320.00 | $101.33 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Prednisolone Acetate | Prednisolone Acetate | 124 | 7,270 | $6,667.46 | 81 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 45 | 3,604 | $462.59 | 22 |
| Brimonidine Tartrate | Brimonidine Tartrate | 32 | 2,605 | $607.85 | 13 |
| Gentamicin Sulfate | Gentamicin Sulfate | 27 | 758 | $308.49 | 27 |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 24 | 1,374 | $712.92 | 12 |
| Timolol Maleate | Timolol Maleate | 21 | 2,000 | $290.94 | 11 |
| Prolensa | Bromfenac Sodium | 21 | 688 | $7,206.48 | — |
| Latanoprost | Latanoprost | 14 | 1,086 | $169.24 | — |
| Atropine Sulfate | Atropine Sulfate | 14 | 812 | $634.22 | — |
| Lotemax Sm | Loteprednol Etabonate | 14 | 442 | $3,491.29 | 14 |
| Dorzolamide-Timolol | Dorzolamide/Timolol/Pf | 11 | 330 | $1,214.53 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2022-09-02NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
NUCC Taxonomy Code: 207WX0107X
An ophthalmologist who specializes in the diagnosis and treatment of vitreoretinal diseases.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OPHTHALMOLOGY
I20070728000041
FL
8729014931
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Pautler Cohen Findlay Eichenbaum White And Crane Mds Pa
2705 W Saint Isabel St, Tampa, FL 336076319
Phone: 8138795795
Secondary Practice Locations
579 S Duncan Ave
Clearwater, FL 337566256
Phone: 7274459110
8801 W Linebaugh Ave Ste 101
Tampa, FL 336261813
Phone: 8773623937
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Ophthalmology (license number reported to NPPES: FL ME90466)
Ophthalmology (license number reported to NPPES: FL ME90466)
Ophthalmology (license number reported to NPPES: FL ME90466)
NPI status registered as active in NPPES database
Registered at 4344 CENTRAL AVE, ST PETERSBURG, FL 337111141 (Tel: 7273230077)
Registered at 4344 CENTRAL AVE, ST PETERSBURG, FL 337111141 (Tel: 7273230077)
Recorded as DAVID EICHENBAUM, M.D.
Ophthalmology (license number reported to NPPES: FL ME90466)
Ophthalmology (license number reported to NPPES: FL ME90466)
NPI status registered as active in NPPES database
Registered at 4344 CENTRAL AVE, ST PETERSBURG, FL 337111141 (Tel: 7273230077)
Registered at 4344 CENTRAL AVE, ST PETERSBURG, FL 337111141 (Tel: 7273230077)
Recorded as DAVID EICHENBAUM, M.D.
Ophthalmology (license number reported to NPPES: FL ME90466)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Ophthalmology Specialists in St Petersburg
- Dr. Kurt Repke, MD
- Dr. Derek Hess, MD
- Dr. Jeffrey Kasper, MD
- Dr. Robert Nelson, MD
- Dr. Nathan Emery, MD
- Dr. David Klein, MD
Mailing Address
4344 Central Ave
St Petersburg, FL 337111141
Phone: 7273230077